a priming dose of ara-c ( 125 to 250 mg/sq m ) followed by a 1-hr infusion of an equal dose of ara-c to patients with acute myelogenous leukemia facilitated the determination of ara-ctp retention in bone marrow and peripheral blood leukemic cells in vivo .
C0023467
acute myelogenous leukemia
C0005953
bone marrow